You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 3, 2024

NUVARING Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Nuvaring patents expire, and what generic alternatives are available?

Nuvaring is a drug marketed by Organon Usa Organon and is included in one NDA.

The generic ingredient in NUVARING is ethinyl estradiol; etonogestrel. There are twenty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; etonogestrel profile page.

Drug patent expirations by year for NUVARING
Drug Prices for NUVARING

See drug prices for NUVARING

Drug Sales Revenue Trends for NUVARING

See drug sales revenues for NUVARING

Recent Clinical Trials for NUVARING

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Lupin Research IncPhase 2
Andrea Roe, MD, MPHPhase 4
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Phase 4

See all NUVARING clinical trials

Pharmacology for NUVARING
Drug ClassEstrogen
Progestin
Mechanism of ActionEstrogen Receptor Agonists
Paragraph IV (Patent) Challenges for NUVARING
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
NUVARING Vaginal Ring ethinyl estradiol; etonogestrel 0.015 mg/24 hour 0.12 mg/24 hour 021187 1 2013-06-17

US Patents and Regulatory Information for NUVARING

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Organon NUVARING ethinyl estradiol; etonogestrel RING;VAGINAL 021187-001 Oct 3, 2001 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for NUVARING

See the table below for patents covering NUVARING around the world.

Country Patent Number Title Estimated Expiration
Russian Federation 2206325 СИСТЕМА ДОСТАВКИ ЛЕКАРСТВЕННЫХ ПРЕПАРАТОВ ДЛЯ ДВУХ ИЛИ БОЛЕЕ АКТИВНЫХ ВЕЩЕСТВ (DRUG DELIVERY SYSTEM FOR TWO OR MORE ACTIVE SUBSTANCES) ⤷  Try a Trial
Czech Republic 9801102 ⤷  Try a Trial
Austria 211646 ⤷  Try a Trial
New Zealand 330145 DRUG DELIVERY SYSTEM, TYPICALLY RING-SHAPED, FOR VAGINAL ADMINISTRATION, WITH STEROIDAL COMPOUNDS DISSOLVED IN POLYMER CORE AND WITH POLYMER SKIN ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for NUVARING

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0771217 CA 2006 00038 Denmark ⤷  Try a Trial PRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804
1214076 SZ 49/2008 Austria ⤷  Try a Trial PRODUCT NAME: WIRKSTOFFKOMBINATION VON ETHINYLESTRADIOL UND DROSPIRENON
0398460 C300221 Netherlands ⤷  Try a Trial PRODUCT NAME: DROSPIRENON EN ETHINYLESTRADIOL; REGISTRATION NO/DATE: RVG 23827 20000307
1453521 15C0050 France ⤷  Try a Trial PRODUCT NAME: ETHINYLESTRADIOL ET MELANGE DE LEVONORGESTREL ET ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: NL 42237 20150320; FIRST REGISTRATION: SK - 17/0017/15-S 20150129
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.